Hi @davybabyk
Just wondering if you have done any reading on the risks of Allo vs Auto. We all are aware of the benefits as touted by the company, however I don't recall seeing any discussion on the associated risks. Are we aware of any issues with blood type matching? The big one for me though is Graft vs Host. This is not a good outcome for a patient to get, but it's not an issue patients with the Auto drugs would face. It looks like a real potential risk with Allo because it's not the patients own Tcells being injected. At some point, I can see patient death from GVHD as an outcome of Allo CarT. Any thoughts?
Why IMU is a multi multi bagger, page-21302
-
- There are more pages in this discussion • 4,574 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.001(0.96%) |
Mkt cap ! $385.8M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.3¢ | 5.2¢ | $69.77K | 1.323M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 43 | 2131678 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 964608 | 16 |
View Market Depth
| Last trade - 14.01pm 19/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |